A process for preparation of once daily controlledrelease formulation of erythromycin a or its deri vative thereof

摘要

The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.